{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T10:19:55Z","timestamp":1777803595364,"version":"3.51.4"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.5206","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T22:04:27Z","timestamp":1447538667000},"page":"2867-2872","source":"Crossref","is-referenced-by-count":11,"title":["Hepatic Angiosarcoma with Dyskeratosis Congenita"],"prefix":"10.2169","volume":"54","author":[{"given":"Norio","family":"Horiguchi","sequence":"first","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kakizaki","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shibusawa","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyasu","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Fernández García MS, Teruya-Feldstein J. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med 5: 157-167, 2014."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol 6: 327-337, 2013.","DOI":"10.1586\/ehm.13.23"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mason PJ, Bessler M. The genetics of dyskeratosis congenita. Cancer Genet 204: 635-645, 2011.","DOI":"10.1016\/j.cancergen.2011.11.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program 2011: 480-486, 2011.","DOI":"10.1182\/asheducation-2011.1.480"},{"key":"5","unstructured":"5. Zinsser F. Atrophia cutis reticularis pigmentione, dystrophia unguium et leukoplakia oris (poikilodermia atrophicans vascularis Jacob). Ikonogr Derm Kyoto 5: 219-223, 1906."},{"key":"6","unstructured":"6. Engman MA. A unique case of reticular pigmentation of the skin with atrophy. Arch Derm Syph Suppl 13: 685-687, 1926."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cole H, Rauschkolb J, Toomey J. Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris. Arch Derm Syph Suppl 21: 71-95, 1930.","DOI":"10.1001\/archderm.1930.01440070079008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood 113: 6549-6557, 2009.","DOI":"10.1182\/blood-2008-12-192880"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Olson TS, Chan ES, Paessler ME, et al. Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita. J Pediatr Hematol Oncol 36: 312-315, 2014.","DOI":"10.1097\/MPH.0b013e318286d4d4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yazawa M, Okuda M, Setoguchi A, et al. Measurement of telomerase activity in dog tumors. J Vet Med Sci 61: 1125-1129, 1999.","DOI":"10.1292\/jvms.61.1125"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zheng YW, Zhang XW, Zhang JL, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol 29: 906-911, 2014.","DOI":"10.1111\/jgh.12506"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Park YS, Kim JH, Kim KW, et al. Primary hepatic angiosarcoma: imaging findings and palliative treatment with transcatheter arterial chemoembolization or embolization. Clin Radiol 64: 779-785, 2009.","DOI":"10.1016\/j.crad.2009.02.019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maeda T, Tateishi U, Hasegawa T, Ojima H, Arai Y, Sugimura K. Primary hepatic angiosarcoma on coregistered FDG PET and CT images. AJR Am J Roentgenol 188: 1615-1617, 2007.","DOI":"10.2214\/AJR.05.0830"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Italiano A, Cioffi A, Penel N, et al. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas. Cancer 118: 3330-3336, 2012.","DOI":"10.1002\/cncr.26599"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Agulnik M, Yarber JL, Okuno SH, et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 24: 257-263, 2013.","DOI":"10.1093\/annonc\/mds237"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ray-Coquard I, Italiano A, Bompas E, et al; French Sarcoma Group (GSF\/GETO). Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF\/GETO). Oncologist 17: 260-266, 2012.","DOI":"10.1634\/theoncologist.2011-0237"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/22\/54_54.5206\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:41:53Z","timestamp":1498261313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/22\/54_54.5206\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":16,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.5206","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}